Differentially expressed genes identified by microarray analysis following oxymatrine treatment of hepatic stellate cell


AIM: To investigate the effects of oxymatrine on the gene expression profile of hepatic stellate cell (HSC) and provide novel insights into the mechanism of oxymatrine against hepatic fibrosis. Methods: HSC was isolated from normal SD by in situ perfusion of collagenase and pronase and density Nycodenz gradient centrifugation. MTT colorimetry was used to study the effect of oxymatrine on the proliferation of HSC. Total RNA and mRNA of quiescent HSC, culture-activated HSC and oxymatrine treated HSC were extracted. Effect of oxymatrine on HSC gene expression profile was detected by oligonucleotide microarray analysis with Affymetrix gene chip rat U230A. Differentially expressed genes were annotated with Gene Ontology (GO) and analyzed with Kyoto encyclopedia of genes and genomes (KEGG) pathway using the Database for Annotation, Visualization and Integrated Discovery. Results: Oxymatrine could inhibit the proliferation of HSC in a dose-dependent manner. A total of 4641 differentially expressed genes were identified by cDNA chip between activated and quiescent HSC, among which 2702 genes were upregulated, and 1939 genes were down-regulated in activated HSC. cDNA microarray uncovered downregulation of 56 genes in response to oxymatrine, the representative genes including alpha 2 type I procollagen, alpha-1 type I collagen, tissue inhibitor of metalloproteinase 1, interleukin 1 beta, early growth response 1, chemokine ligand 2, chemokine ligand 1, CTGF, TGFβ1. The most enriched GO terms included response to wounding, inflammatory response, cell migration, cell motility, wound healing, TGFβ receptor signaling pathway. KEGG pathway analysis revealed that oxymatrine affected the ECM-receptor interaction, focal adhesion, cytokine-cytokine recaptor interaction, TGFβ signaling pathway, MAPK signaling pathway. There were 37 genes upregulated significantly following oxymatrine treatment. The most enriched GO terms included oxidation reduction, negative regulation of lipoprotein oxidation, regulation of lipoprotein oxidation, steroid metabolic process, regulation of lipase activity. Six genes were confirmed with QPCR, consistent with microarray. Conclusion: The mechanism of oxymatrine in inhibiting liver fibrogenesis is associated with multi-genes and multi-pathways regulation.

Share and Cite:

Hu, J. , Dong, S. , Wang, Q. , Jian, Y. , Hu, L. , Wang, L. , He, Y. , Yang, G. , Wang, J. and Xiong, W. (2013) Differentially expressed genes identified by microarray analysis following oxymatrine treatment of hepatic stellate cell. Journal of Biomedical Science and Engineering, 6, 49-57. doi: 10.4236/jbise.2013.68A2007.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Luk, J.M., Wang, X., Liu, P., Wong, K.F., Chan, K.L., Tong, Y., Hui, C.K., Lau, G.K. and Fan, S.T. (2007) Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: From laboratory discovery to clinical evaluation. Liver International, 27, 879-890. doi:10.1111/j.1478-3231.2007.01527.x
[2] Deng, Z.Y., Li, J., Jin, Y., Chen, X.L. and Lü, X.W. (2009) Effect of oxymatrine on the p38 mitogen-activated protein kinases signaling pathway in rats with CCl4 induced hepatic fibrosis. Chinese Medical Journal (English), 122, 1449-1454.
[3] Wu, X.L., Zeng, W.Z., Jiang, M.D., Qin, J.P. and Xu, H. (2008) Effect of oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World Journal of Gastroenterology, 14, 2100-2105. doi:10.3748/wjg.14.2100
[4] Shi, G.F. and Li, Q. (2005) Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo. World Journal of Gastroenterology, 11, 268-271.
[5] Wu, C.S., Piao, X.X., Piao, D.M., Jin, Y.R. and Li, C.H. (2005) Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha. World Journal of Gastroenterology, 11, 122-126.
[6] Yu, X.H., Zhu, J.S., Yu, H.F. and Zhu, L. (2004) Immunomodulatory effect of oxymatrine on induced CCl4-hepatic fibrosis in rats. Chinese Medical Journal (English), 117, 1856-1858.
[7] Mao, Y.M., Zeng, M.D., Lu, L.G., Wan, M.B., Li, C.Z., Chen, C.W., Fu, Q.C., Wang, J.Y., She, W.M., Cai, X., Ye, J., Zhou, X.Q., Wang, H., Wu, S.M., Tang, M.F., Zhu, J.S., Chen, W.X. and Zhang, H.Q. (2004) Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: A randomized, double blind, placebo-controlled, multicenter clinical study. World Journal of Gastroenterology, 10, 3269-3273.
[8] Lin, M., Yang, L.Y., Li, W.Y., Peng, Y.P. and Zheng, J.K. (2009) Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. Journal of International Medical Research, 37, 1411-1149. doi:10.1177/147323000903700515
[9] Cheng, Y., Ping, J., Xu, H.D., Fu, H.J. and Zhou, Z.H. (2006) Synergistic effect of a novel oxymatrine-baicalin combination against hepatitis B virus replication, alpha smooth muscle actin expression and type I collagen synthesis in vitro. World Journal of Gastroenterology, 12, 5153-5159.
[10] Liu, J., Manheimer, E., Tsutani, K. and Gluud, C. (2003) Medicinal herbs for hepatitis C virus infection: A Cochrane hepatobiliary systematic review of randomized trials. The American Journal of Gastroenterology, 98, 538-544. doi:10.1111/j.1572-0241.2003.07298.x
[11] Jian, Y.C., Li, W., He, Y., Jiang, M., Liu, Y.B. and Xiong, W.J. (2012) Effect of oxymatrine on hepatic gene expression profile in experimental liver fibrosis of rats. Chinese Journal of Integrative Medicine, 18, 445-450. doi:10.1007/s11655-012-1115-x
[12] Kang, Y.J. (2008) Herbogenomics: From traditional Chinese medicine to novel therapeutics. Experimental Biology and Medicine, 233, 1059-1065. doi:10.3181/0802-MR-47
[13] Weiskirchen, R. and Gressner, A.M. (2005) Isolation and culture of hepatic stellate cells. Methods in Molecular Medicine, 117, 99-113.
[14] Huang, da W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4, 44-57. doi:10.1038/nprot.2008.211
[15] Guzman, J.R., Koo, J.S., Goldsmith, J.R., Mühlbauer, M., Narula, A. and Jobin, C. (2013) Oxymatrine prevents NFκB nuclear translocation and ameliorates acute intestinal inflammation. Scientific Reports, 3, 1629. doi:10.1038/srep01629
[16] Wu, X.L., Zeng, W.Z., Jiang, M.D., Qin, J.P. and Xu, H. (2008) Effect of oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World Journal of Gastroenterology, 14, 2100-2105. doi:10.3748/wjg.14.2100
[17] Shen, B.S. and Song, X.W. (2008) Effects of oxymatrine on serum cytokines and hepatic fibrotic indexes in patients with chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Zazhi, 28, 17-19.
[18] Yang, W., Zeng, M., Fan, Z., Mao, Y., Song, Y., Jia, Y., Lu, L., Chen, C.W., Peng, Y.S. and Zhu, H.Y. (2002) Prophylactic and therapeutic effect of oxymatrine on Dgalactosamine-induced rat liver fibrosis. Zhonghua Gan Zang Bing Za Zhi, 10, 193-196.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.